首页> 外国专利> -CD73 ANTI-CD73 ANTIBODIES AND USES THEREOF

-CD73 ANTI-CD73 ANTIBODIES AND USES THEREOF

机译:-CD73抗CD73抗体及其用途

摘要

An anti-CD73 antibody or fragment thereof is provided. Thus, the antibody or fragment comprises a VH CDR1 of SEQ ID NO: 1, a VH CDR2 of SEQ ID NO: 2, a VH CDR3 of SEQ ID NO: 3, a VL CDR1 of SEQ ID NO: 4, a VL CDR2 of SEQ ID NO: 5, and SEQ ID NO: 6 VL CDR3, or these variants. More generally, antibodies or fragments thereof are described that have specificity for one or more amino acid residues selected from the C-terminal half of a human CD73 protein, such as the C-terminal domain. Specific epitope amino acids in these domains include Y345, D399, E400, R401 and R480. Also provided are methods of using the antibody or fragment thereof to treat and diagnose a disease such as cancer.
机译:提供了抗CD73抗体或其片段。因此,抗体或片段包含SEQ ID NO:1的VH CDR1,SEQ ID NO:2的VH CDR2,SEQ ID NO:3的VH CDR3,SEQ ID NO:4的VL CDR1,VL CDR2。 SEQ ID NO:5和SEQ ID NO:6 VL CDR3的序列或这些变体。更一般地,描述了对选自人CD73蛋白的C末端一半的一个或多个氨基酸残基具有特异性的抗体或其片段,例如C末端结构域。这些结构域中的特定表位氨基酸包括Y345,D399,E400,R401和R480。还提供了使用抗体或其片段治疗和诊断疾病例如癌症的方法。

著录项

  • 公开/公告号KR20190105122A

    专利类型

  • 公开/公告日2019-09-11

    原文格式PDF

  • 申请/专利权人 아이-맵;

    申请/专利号KR20197025714

  • 申请日2018-01-23

  • 分类号C07K16/28;A61K35/17;A61K39;A61P35;C12N5/0783;G01N33/574;

  • 国家 KR

  • 入库时间 2022-08-21 11:49:49

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号